Vitamin C for Sepsis and Severe ARDS
In a 2019 randomized trial, high-dose vitamin C infusion did not reduce organ failure scores at 96 hours or improve biomarkers of inflammation and vascular injury at 168 hours in patients with sepsis-induced severe acute respiratory failure in U.S. intensive care units (ICUs). Alpha A. Fowler III, MD of Virginia Commonwealth University in Richmond presents findings from the CITRIS-ALI trial at the European Society of Intensive Care Medicine (ESICM) 32nd Annual Congress, LIVES 2019, on October 2 in Berlin. See https://ja.ma/2qJP94f for complete trial details. Video used with permission.

▶︎
Vitamin C, Mitochondria, and Cellular Energy

▶︎
Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction

▶︎
Fluids in the ICU

▶︎
PF Medications Explained: What to expect, and benefits & risks

▶︎
The Selective Vasopressin Receptor Agonist Selepressin for Septic Shock

▶︎
Latest developments in bladder cancer research - World Bladder Cancer Patient Forum 2025

▶︎
health shouldn't be a competition

▶︎
Linus Pauling - Conversations with History

▶︎
Drug therapy for COPD and asthma

▶︎
Evidence-based use of HFNC: The development of Clinical Practice Guidelines

▶︎
New data and insight from vitamin C studies - Professor Margreet Vissers

▶︎
Replay - Webinar - Chronic Fatigue and Burnout

▶︎
Brian Cox- The Fermi Paradox Will Change How You See The Universe

▶︎
"The truth about mobile phone and wireless radiation" -- Dr Devra Davis

▶︎
Myopia: A Modern Yet Reversible Disease — Todd Becker, M.S. (AHS14)

▶︎
Liposome Science - Thomas E. Levy, MD, JD

▶︎
Assisted breathing in ARDS patients

▶︎
PCI MENA 2026 – Day 1, Session 4

▶︎
EMSL LEARN Webinar: Intro to Retrieval-Augmented Generation (RAG)

▶︎
